Paradoxical skin lesions induced by IL-17 inhibitors in SAPHO syndrome
J Dermatolog Treat
.
2024 Dec;35(1):2295239.
doi: 10.1080/09546634.2023.2295239.
Epub 2023 Dec 28.
Authors
Yuan Li
1
,
Fanzhang Meng
1
,
Haixu Jiang
2
,
Qiuwei Peng
3
,
Jingyuan Fu
2
,
Dan Yin
4
,
Xiujuan Hou
5
,
Chen Li
3
Affiliations
1
School of Clinical Medicine, Beijing University of Chinese Medicine, Beijing, China.
2
School of Chinese Materia, Beijing University of Chinese Medicine, Beijing, China.
3
Department of Rheumatology, Fangshan Hospital, Beijing University of Chinese Medicine, Beijing, China.
4
Department of Endocrinology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
5
Department of Rheumatology, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China.
PMID:
38153122
DOI:
10.1080/09546634.2023.2295239
No abstract available
Publication types
Case Reports
MeSH terms
Acquired Hyperostosis Syndrome* / drug therapy
Acquired Hyperostosis Syndrome* / pathology
Humans
Interleukin-17* / antagonists & inhibitors
Skin Diseases* / chemically induced
Substances
Interleukin-17